logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Prolynx LLC

Calculating rank
USPTO Granted Patents = 21


Forward Citations = 158

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Gary W Ashley (17 out of 57 patents)

silverMedal Daniel V Santi (15 out of 62 patents)

bronzeMedal Jeffrey C Henise (6 out of 6 patents)

4.  Eric L Schneider (5 out of 6 patents)

5.  Brian R Hearn (4 out of 11 patents)

6.  Shaun Fontaine (3 out of 3 patents)

7.  Richard T W Wilson (1 out of 1 patent)

8.  Jonathan J H G Oskam (1 out of 1 patent)

9.  Brian Yao (1 out of 1 patent)

10.  John A Hangasky, Iii (1 out of 1 patent)

11.  Samuel J Pfaff (1 out of 1 patent)

12.  Jeffrey C Henise (1 out of 1 patent)

13.  Daniel V Santi (1 out of 1 patent)


21 patents:

1. 12758661 - Steam sterilization of hydrogels crosslinked by beta-eliminative linkers (2026-10-13),
2. 12697395 - SLOW-RELEASE CYTOKINE CONJUGATES (2026-08-04),
3. 12478680 - HYDROGELS WITH BIODEGRADABLE CROSSLINKING (2025-11-25),
4. 12472261 - Conjugated inhibitors of DNA damage response (2025-11-18),
5. 12364771 - Conjugation linkers (2025-07-22),
6. 11730836 - Synergistic cancer treatment (2023-08-22),
7. 11454861 - Hydrogels with biodegradable crosslinking (2022-09-27),
8. 11181803 - Hydrogels with biodegradable crosslinking (2021-11-23),
9. 11179470 - Hydrogels with biodegradable crosslinking (2021-11-23),
10. 10967925 - Mountable cleat apparatus (2021-04-06),
11. 10413594 - Conjugates of somatostatin analogues (2019-09-17),
12. 10398779 - Hydrogels with biodegradable crosslinking (2019-09-03),
13. 10342792 - Slow-release conjugates of SN-38 (2019-07-09),
14. 10086049 - Conjugates of somatostatin analogues (2018-10-02),
15. 10016411 - Slow-release conjugates of SN-38 (2018-07-10),
Company Overview
Prolynx LLC is a technology company based in San Francisco, specializing in advanced solutions for the life sciences sector. The organization focuses on developing innovative software and systems that enhance research and operational efficiencies in pharmaceutical and biotechnology industries. Prolynx is dedicated to improving data management and analysis, facilitating better decision-making processes in drug development and clinical trials. Its expertise lies in integrating cutting-edge technology with scientific research to drive advancements in healthcare.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Prolynx LLC USPTO Patent Assignee Logo
21 Patents

#225 in San Francisco, CA

#3,768 in California

#15,719 in US

#30,018 in the World

San Francisco, CA (US)
San Francisco, CA, United States of America

Prolynx LLC

Forward Citations = 158

13 inventors:

goldMedal Gary W Ashley (17 out of 57 patents)

silverMedal Daniel V Santi (15 out of 62 patents)

bronzeMedal Jeffrey C Henise (6 out of 6 patents)

4.  Eric L Schneider (5 out of 6 patents)

5.  Brian R Hearn (4 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Prolynx LLC. Retrieved from https://idiyas.com/company/prolynx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…